Clinical trial

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment…

NCT04246281 · SPR Therapeutics, Inc., Industry · Active, not recruiting

Key facts

NCT number NCT04246281
Title The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain
Official title A Randomized, Controlled, Multicenter Trial of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain
Lead sponsor SPR Therapeutics, Inc., Industry
Collaborators United States Department of Defense U.S. Fed
Status Active, not recruiting
Study type Interventional
Conditions Low Back Pain, Back Pain
Intervention type Device, Procedure
Interventions SPRINT Peripheral Nerve Stimulation (PNS) System, Standard interventional management of low back pain
Enrollment 230
Start date Jun 17, 2020
Primary completion Apr 1, 2026
Completion Apr 1, 2027
First posted Jan 29, 2020
Last update posted Dec 15, 2025
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies